Jieyi Ma Selected Research

Messenger RNA (mRNA)

10/2023	The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma.
12/2021	METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.
12/2021	METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression.
1/2019	High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma.
10/2018	Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jieyi Ma Research Topics

Disease

15	Neoplasms (Cancer) 04/2024 - 01/2014
3	Squamous Cell Carcinoma of Head and Neck 04/2024 - 10/2023
3	Esophageal Squamous Cell Carcinoma 03/2024 - 12/2021
3	Carcinogenesis 01/2023 - 01/2022
2	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 12/2021
2	Atherosclerosis 12/2020 - 05/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2018
2	Neoplasm Metastasis (Metastasis) 11/2018 - 04/2015
2	Breast Neoplasms (Breast Cancer) 08/2017 - 01/2017
2	Triple Negative Breast Neoplasms 01/2017 - 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Neuroblastoma 09/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Microcephaly 01/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Pathologic Processes 12/2020
1	Arteriosclerosis Obliterans 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 04/2015
1	Wounds and Injuries (Trauma) 01/2015

Drug/Important Bio-Agent (IBA)

6	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2020
6	MethyltransferasesIBA 01/2023 - 12/2021
5	Messenger RNA (mRNA)IBA 10/2023 - 10/2018
5	Transfer RNA (tRNA)IBA 01/2023 - 12/2021
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2020
2	Codon (Codons)IBA 01/2023 - 12/2021
2	N-methyladenosineIBA 01/2022 - 12/2021
2	6-methyladenineIBA 01/2022 - 12/2021
2	18S Ribosomal RNAIBA 01/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 05/2017 - 01/2014
1	NitrosaminesIBA 04/2024
1	anlotinibIBA 02/2024
1	AcetyltransferasesIBA 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Ribosomal RNAIBA 01/2022
1	Long Noncoding RNAIBA 12/2020
1	Antisense RNA (Anti-Sense RNA)IBA 12/2020
1	Nudix HydrolasesIBA 01/2020
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	CateninsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 11/2018
1	ParaffinIBA 11/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2018
1	Aryldialkylphosphatase (Paraoxonase)IBA 11/2018
1	diacetyldichlorofluoresceinIBA 08/2017
1	Hemin (Panhematin)FDA Link 08/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2017
1	oxidized low density lipoproteinIBA 05/2017
1	Small Untranslated RNAIBA 05/2017
1	NVP-AEW541IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 04/2015
1	NF-kappa B (NF-kB)IBA 04/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2015
1	5-ethynyl-2'-deoxyuridineIBA 01/2015

Therapy/Procedure

1	Immunotherapy 04/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Therapeutics 01/2017